These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 14510794

  • 21. Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timolol.
    Costagliola C, Campa C, Parmeggiani F, Incorvaia C, Perri P, D'Angelo S, Lamberti G, Sebastiani A.
    Br J Clin Pharmacol; 2007 Mar; 63(3):376-9. PubMed ID: 16981897
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of dorzolamide timolol combination versus timolol 0.5% on ocular bloodflow in patients with primary open-angle glaucoma.
    Harris A, Jonescu-Cuypers CP, Kagemann L, Nowacki EA, Garzozi H, Cole C, Martin B.
    Am J Ophthalmol; 2001 Oct; 132(4):490-5. PubMed ID: 11589868
    [Abstract] [Full Text] [Related]

  • 27. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K, Shirato S.
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the Effects of Dorzolamide/Timolol Fixed Combination versus Latanoprost on Intraocular Pressure and Ocular Perfusion Pressure in Patients with Normal-Tension Glaucoma: A Randomized, Crossover Clinical Trial.
    Lee NY, Park HY, Park CK.
    PLoS One; 2016 Aug; 11(1):e0146680. PubMed ID: 26756747
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Visual function, optic nerve structure, and ocular blood flow parameters after 1 year of glaucoma treatment with fixed combinations.
    Januleviciene I, Ehrlich R, Siesky B, Nedzelskiené I, Harris A.
    Eur J Ophthalmol; 2009 Aug; 19(5):790-7. PubMed ID: 19787599
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N, Rossetti L, Bottoli A, Fumagalli E, Fogagnolo P.
    Arch Ophthalmol; 2003 Apr; 121(4):453-7. PubMed ID: 12695241
    [Abstract] [Full Text] [Related]

  • 33. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].
    Schmidt KG, von Rückmann A, Becker R, Pillunat LE.
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Efficacy of the latanoprost versus timolol/dorzolamide combination therapy in patients with primary open angle glaucoma.
    Rismanchian A, Eslami F, Moeini H, Attarzade H, Naderibeni A.
    Saudi Med J; 2008 Mar; 29(3):384-7. PubMed ID: 18327364
    [Abstract] [Full Text] [Related]

  • 37. Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure.
    Kimal Arici M, Topalkara A, Güler C.
    Int Ophthalmol; 1998 Mar; 22(1):37-42. PubMed ID: 10090447
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.